Pharmsville Co., Ltd.

₩3,390As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:318010Healthcare
Country South Korea
PE (Fwd) •••
TSR 7Y CAGR (15.37%)
Div yield 5.90%
ROE 4.57%
Pharmaceutical Preparations
Beta (5Y) 0.11
PE TTM 8.765
TSR TTM 1.56%
Mkt cap ₩26.20B
ROIC (1.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,205
24.05%
(27.54%)
Hold 2|3|6|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
70.04
69.75
70.93
67.63
20.68%
11.00%
1.88%
(7.40%)
Revenue₩B
1.271
1.313
1.325
1.288
14.38%
12.81%
7.67%
3.90%
Peers (US$19.32M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
9.863
(0.071)
(0.069)
EBIT/Intx
0.626
0.137
0.108
Own earn%
631.06
(116.78)
(127.29)
Sh yield%
54.28
33.09
30.92
Owners
Insiders/Inst%
8.52
68.50
Short interest%
1.47
SBC / revenue%
2.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
33–45
$1 testx
0.0
Incr. ROIC%
4